Mind Medicine Mindmed Inc (NQ: MNMD )
3.535 -0.005 (-0.14%) Streaming Delayed Price Updated: 4:00 PM EDT, May 26, 2023 Add to My Watchlist
All News about Mind Medicine Mindmed Inc
Mind Medicine: Q1 Earnings Insights
May 04, 2023
Biotech Company Discovers What May Be The First New Compounds Of Psilocybin In History NY-based biotech platform Terran Biosciences announced the publication of an international PCT patent application...
Earnings Outlook For Mind Medicine
May 03, 2023
Clinical-stage biopharma company Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) has reported its unaudited financial results for the quarter ended March 31, 2023, and shared the period’s business...
April Psychedelic Drug Stocks Recap: The Ups And Downs
April 30, 2023
Via Talk Markets
MindMed to Participate in May Investor Conferences
April 26, 2023
Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More
April 24, 2023
LSD Trial Study Shows Potential For Major Depression Psychedelics biopharma company Mind Medicine Inc. (NASDAQ: MNMD) recently shared positive topline data from an advanced clinical trial of LSD as a...
Cybin, Mind Medicine Among Top Psychedelic Movers Of Today
April 19, 2023
Psychedelic Stock Gainers And Losers From April 18, 2023
April 18, 2023
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following